Загрузка...
RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine
BACKGROUND: Gemcitabine has been widely used as a chemotherapeutic drug. However, drug resistance, short half-life and side effects seriously decrease its chemotherapeutic efficacy. PURPOSE: The object of preparing RGDV-gemcitabine was to prolong the half-life, to overcome drug resistance and to eli...
Сохранить в:
| Опубликовано в: : | Int J Nanomedicine |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6737205/ https://ncbi.nlm.nih.gov/pubmed/31686807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S212978 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|